NIH Ends Funding for Animal‑Only Studies: What This Means for Biomedical Research and 3D Cell Culture The National Institutes of Health (NIH) has announced a major policy change: ending funding for research projects based solely on animal studies. Moving forward, all NIH grant applications must include non-animal methods (NAMs) such as 3D cell culture models, […]
Gelomics Achieves Triple ISO Certification, Reinforcing Global Leadership in Biomedical Innovation We’re proud to share an exciting milestone for the Gelomics team: we’ve officially been awarded ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications! These internationally recognized standards reflect our commitment to quality, environmental responsibility, and the health and safety of our team. The […]
Gelomics Awarded $948K Industry Growth Program Grant to Accelerate Commercialisation of AI-Powered 3D Tissue Culture Platform. 4 June 2025 Gelomics is proud to announce the award of $948,066 in non-dilutive grant funding through the Industry Growth Program under the Commercialisation and Growth stream. The $1.9 million project will fast-track the commercialisation of Gelomics’ next-generation AI-assisted […]
Gelomics Partners with Morpho Biotech for Benelux Distribution At Gelomics, we are committed to making cutting-edge, animal-free research tools more accessible to scientists around the globe. Today, we’re excited to announce a new strategic partnership with Morpho Biotech, who will serve as the exclusive distributor of Gelomics products in the Netherlands, Belgium, and Luxembourg (Benelux) […]
Gelomics Partners with BioNordika Group to Expand Presence Across the Nordics and Baltics We’re excited to announce that Gelomics is now a registered supplier on BioNordika! Our cutting-edge 3D cell culture technologies are now accessible to researchers across the Nordic and Baltic regions. BioNordika is a trusted distributor representing a wide range of world-leading and […]
Gelomics Welcomes Distinguished Professor Gail Risbridger to its Scientific Advisory Board Gelomics, a pioneering Australian biotech firm redefining the future of drug development with its cutting-edge 3D tissue culture technologies, is delighted to announce the appointment of Distinguished Professor Gail Risbridger AM to its Scientific Advisory Board. Professor Risbridger joins a team of internationally recognized […]
Gelomics Partners with SLS to Expand 3D Tissue Culture Access Across the UK and Ireland Gelomics is proud to announce a strategic distribution partnership with Scientific Laboratory Supplies (SLS), the United Kingdom’s largest independent supplier of laboratory products. Under this agreement, SLS will serve as Gelomics’ exclusive distributor in the UK and Ireland, significantly expanding […]
Gelomics Now Available on Scientist.com We are excited to announce that Gelomics is now a supplier on Scientist.com! Through this leading platform for scientific sourcing, we are providing simple, fast and reliable access to our innovative 3D tissue culture products and services in the US. Why choose Gelomics on Scientist.com? Since 2007, Scientist.com has become […]
Gelomics Expands Global Presence with New Distribution Partner, Voden Medical In Italy Gelomics proudly announces a strategic partnership with Voden Medical. Voden Medical is a renowned provider of advanced diagnostic and life science solutions in Italy. Under this agreement, Voden Medical will serve as Gelomics’ exclusive distributor in the Italian market. This partnership, effective January […]
Gelomics partners with Bucher Biotec AG for Product Distribution in Switzerland Gelomics is pleased to announce a new strategic partnership with Bucher Biotec AG, a leading provider of advanced life science solutions in Switzerland & Lichtenstein. Under this agreement, Bucher Biotec will serve as Gelomics’ exclusive distributor across the Swiss market. This partnership marks an […]
